Post-marketing safety surveillance of Haemophilus influenzae Type b conjugate vaccine in children aged 3 months to 5 years in Jiangsu, China
< .001). No vaccine-related serious adverse reactions were reported in either surveillance system. This post-marketing surveillance study confirms that the Hib conjugate vaccine demonstrates a favorable safety profile in children aged 3 months to 5 y, with no safety-associated risks identified.
Authors
- Rong Tang (ORCID: https://orcid.org/0000-0002-1475-372X)
- Yi Zhou (ORCID: https://orcid.org/0000-0002-0273-007X)
- Xinglu Peng
- J X Li
- Ruifan Shen
- Mingwei Wei
Institutions
- China Pharmaceutical University (CN)
- Jiangsu Provincial Center for Disease Control and Prevention (CN)
Publication Details
- Journal
- Human Vaccines & Immunotherapeutics
- Published
- 2026-05-30
- DOI
- https://doi.org/10.1080/21645515.2026.2677876
- Primary Topic
- Bacterial Infections and Vaccines
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Jiangsu Province for Distinguished Young Scholars